{"symbol": "BOLD", "companyName": "Audentes Therapeutics Inc.", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.audentestx.com", "description": "Audentes Therapeutics Inc is a biotechnology company. It is engaged in developing and commercializing gene therapy products for patients suffering from serious, life-threatening rare diseases caused by single gene defects.", "CEO": "Matthew R. Patterson", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}